As APP/PS1 mouse exhibits a significant increase in plaque burden and severely impaired cognitive behaviors at the age of 10 months (Liu et al., 2020), thus, 10-month-old AD mice and age-matched NP65-deficient AD mice were used in present study. This evidence concerns the gene APP and Alzheimer disease.